大家健康（下旬版）
大傢健康（下旬版）
대가건강（하순판）
FOR ALL HEALTH
2014年
10期
521-521
,共1页
二甲双胍%骨质疏松%2型糖尿病
二甲雙胍%骨質疏鬆%2型糖尿病
이갑쌍고%골질소송%2형당뇨병
metformin%osteoporosis%T2DM
目的：观察新诊断2型糖尿患者二甲双胍对骨质疏松的影响。方法：随机将60例入选患者分为对照组和治疗组，每组30例，治疗组给予二甲双胍，对照组给予安慰剂治疗，分别在治疗前后检测患者骨密度。结果：治疗组患者骨密度较对照组高，差异有统计学意义（P<0.05)。结论：二甲双胍在降低血糖的同时可抑制骨质疏松。
目的：觀察新診斷2型糖尿患者二甲雙胍對骨質疏鬆的影響。方法：隨機將60例入選患者分為對照組和治療組，每組30例，治療組給予二甲雙胍，對照組給予安慰劑治療，分彆在治療前後檢測患者骨密度。結果：治療組患者骨密度較對照組高，差異有統計學意義（P<0.05)。結論：二甲雙胍在降低血糖的同時可抑製骨質疏鬆。
목적：관찰신진단2형당뇨환자이갑쌍고대골질소송적영향。방법：수궤장60례입선환자분위대조조화치료조，매조30례，치료조급여이갑쌍고，대조조급여안위제치료，분별재치료전후검측환자골밀도。결과：치료조환자골밀도교대조조고，차이유통계학의의（P<0.05)。결론：이갑쌍고재강저혈당적동시가억제골질소송。
Objective:To study the effect of metformin on osteoporosis in patients with newly diagnosed type 2 diabetes mellitus(T2DM). Methods: sixty subjects were enrolled and assigned to the treatment group received metformin (n=30) and the control group received the placebo (n=30). The bone miner-al density(BMD) was measured before and after the treatment. Results: Compaired to the control group? the treatment group noted a higher (P<C0. 05). Conclusion: Metformin can inhibit the osteoporosis as well as improving the hyperglycemia.
